openPR Logo
Press release

Top 3 reasons to attend the HPAPI USA conference 2019

09-26-2019 10:57 AM CET | Health & Medicine

Press release from: SMI

HPAPI USA conference 2019

HPAPI USA conference 2019

SMI Reports: Overview of networking opportunities and key features to expect from the upcoming HPAPI USA conference 2019, in Boston

With is less than 4 weeks until the 2019 HPAPI USA Conference 2019 taking place in Boston on 21st – 22nd October, key features of the two-day agenda as been released. The highly anticipated conference will gather the growing API community, filled with industry thought leaders and drug development experts involved in: HPAPI projects and risk assessments, containment strategies, the current ADCs landscape, manufacturing technologies and crisis management.

Meet and network with the leaders in the US HPAPI market including: AbbVie, Agios Pharmaceuticals, Allergan, Bionavigen, BSP Pharmaceuticals, Cambrex Corporation, Ewha Womans University, FPS Containment, Keith Jensen Consulting, Lonza Pharma and Biotech, Novartis Pharmascience, Purdue Pharma, SafeBridge Consultants, Sakari Consultants, SKAN, Takeda and Taro Pharmaceuticals.

As there is less than four weeks remaining until the conference, places are highly limited. Interested parties are advised to register soon to secure a place. Register at www.hpapi-usa.com/openPR7

Along with the great networking opportunities in the event, other key features include:

1) Demonstrating that exposure controls are effective
- Examples of control devices and their performance
- Where does the data come from?
- ADCs – can we really measure nanogramme concentrations?
Charlyn Reihman, Principal Occupational Health Consultant, SafeBridge Consultants USA

2) Emergency procedures for HPAPI Disasters and how to manage an HPAPI accident
- Gain-awareness of dangers of unforeseen circumstances and accidents for HPAPIs and learn of the fail-safes and back-up procedures that can be implemented to mitigate risk
- Understand the long term cost savings from planning and implementing emergency procedures
- How to manage risks in an HPAPI workplace environment to minimise the chance of disasters
- Learn of the best practices of disposing HPAPI waste
Aysha Ovais, EHS Professional, Taro Pharmaceuticals

3) Effective and safe containment solutions for biologics based HPAPIs along with cleaning and cross contamination requirements
- Regulatory requirements for highly potent biologics-based Pharmaceuticals
- Requirements for aseptic manufacturing and Containment
- Cleaning and Cross Contamination Requirements
Richard Denk, Head Sales Containment, SKAN

For the full, event details and speaker line-up, the brochure is available to download at www.hpapi-usa.com/openPR7

Proudly Sponsored by: BSP Pharmaceuticals | LONZA | Minakem | SafeBridge Consultants

Highly Potent Active Pharmaceutical Ingredients USA
Conference: October 21st – 22nd
Workshops: October 23rd
Venue: Sheraton Boston Hotel, USA

For sponsorship, exhibition and branding enquiries, please contact Alia Malick on +44 (0)20 7827 6168 or amalick@smi-online.co.uk

For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164 or nhoward@smi-online.co.uk

--END—

45 Curlew Street

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Top 3 reasons to attend the HPAPI USA conference 2019 here

News-ID: 1838004 • Views: 730

More Releases from SMI

Senior US officials from fuel policy teams and combat wings to present at Milita …
SMi reports: Senior US officials will be presenting at the 21st Annual Military Airlift Air-to-Air Refuelling conference in Seville, this December Air-to-air refuelling remains a key mission multiplier, utilised extensively in Operation Inherent Resolve to extend flight times for bombing runs against ISIS. As the US Air Force explores the greater utilisation of commercial refuellers for CONUS operations to free military assets for combat and international deployment there is a critical
Senior experts to discuss Naval Mine Countermeasures at Unmanned Maritime System …
The challenge posed by potential adversary mining capabilities is real and growing. For all navies, there is only one way to completely “Take the sailor out of the minefield,” and that is to leverage unmanned technologies to hunt and destroy mines from a distance.* By embracing technological advancements in unmanned systems, such as UUVs and USVs, they could sweep large portions of the sea while minimizing the risk to sailors. For
Military Robotics and Autonomous Systems 2020 announced as a Virtual Event
SMi Reports: Due to the ongoing challenges surrounding COVID-19, Military Robotics and Autonomous Systems in September will now run as a virtual event. With the continued uncertainty surrounding large gatherings in the UK, SMi Group have made the decision to turn the 3rd annual Military Robotics and Autonomous Systems Conference on the 2nd-3rd September 2020 into a fully interactive virtual meeting. All attendance by military and government will be free of charge
04-07-2020 | Health & Medicine
SMI
Associates of Cape Cod Webinar on Recombinant Chromogenic Assay as Alternate Met …
SMi Reports: Associates of Cape Cod to host an online webinar taking place on Wednesday 29th April 2020. SMi Group is delighted to announce a free webinar led by Associates of Cape Cods on 'Recombinant Chromogenic Assay as Alternate Methods for Bacterial Endotoxins Test (BET)' taking place on 29th April 2020 at 10am EDT (3pm BST - UK time). The webinar will aim to review the global perspective on the use

All 5 Releases


More Releases for API

Terminating Twitter API Integrations
Thexyz Inc, the leading private email service that protects people and their data announces that a Twitter authentication apps developed by Thexyz will be discontinued and no longer supported. Thexyz focuses on security, privacy, freedom, and an open internet that respects the rights of individuals. It is a goal to work with organizations that share these values and discontinue support for services that do not. Thexyz has developed applications
Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles.   Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform.   Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The